Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jiedu Tongluo granules for post-stroke depression
NCT03147053Phase 1Completed
- Sponsor
- Xiyuan Hospital
- Start
- Apr 2017
- Primary completion
- Jul 2017
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in major depressive disorder (MDD) comparing Jiedu Tongluo granules with Placebo (2 arms). Primary endpoints: 17-item Hamilton Depression Scale at 8 weeks and Barthel Index at 8 weeks. Started Apr 2017; status: completed.
02
Drugs
Jiedu Tongluo Tiaogan Decoction
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03147053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03147053.